|
End-of-day quote
New Zealand S.E.
18/09/2026
|
5-day change | 1st Jan Change | ||
| 4.300 NZD | +0.23% |
|
-2.05% | +27.22% |
| 09/09 | Aft Pharmaceuticals Limited Partners with Mark Cuban Cost Plus Drug Company to Bring Combogesic to the U.S | CI |
| 31/07 | AFT Pharmaceuticals Limited - Shareholder/Analyst Call |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.23% | -2.05% | 0.00% | +11.69% | +27.22% | +65.38% | +23.21% | +3.12% | +43.33% | 258M | |
| -0.62% | +2.44% | -6.76% | +4.04% | +6.35% | +49.81% | +100.06% | +393.40% | +1,343.80% | 1,027B | |
| +0.02% | +1.63% | -0.44% | +18.18% | +30.43% | +54.98% | +66.13% | +64.77% | +129.40% | 651B | |
| +0.12% | +2.69% | +1.97% | +21.96% | +15.55% | +18.94% | +71.51% | +148.15% | +319.69% | 467B | |
| -1.22% | +3.66% | -1.14% | +11.85% | +8.71% | +36.44% | +38.32% | +4.48% | +47.13% | 350B | |
| -0.79% | +2.73% | -8.33% | -2.49% | +5.02% | +19.03% | +25.08% | +49.07% | +46.44% | 268B | |
| +0.58% | +6.76% | +5.88% | -4.97% | -9.35% | +11.13% | +16.52% | +46.05% | +146.11% | 257B | |
| +0.90% | +1.45% | -9.99% | +13.39% | +16.96% | +38.78% | +45.47% | +77.96% | +123.37% | 205B | |
| +0.79% | +1.84% | -4.99% | +0.52% | -13.44% | -28.27% | -56.71% | -11.24% | +82.35% | 190B | |
| -0.07% | +4.77% | +4.97% | +21.66% | +22.67% | +32.52% | +99.11% | +112.19% | +90.62% | 187B | |
| -0.42% | -0.81% | +0.90% | +9.06% | +10.42% | +13.85% | -18.27% | -37.79% | -18.29% | 158B | |
| -1.92% | -1.98% | -4.34% | +11.87% | +11.45% | +30.52% | +43.54% | +172.12% | +453.64% | 131B | |
| -0.33% | -1.70% | -5.28% | +15.85% | +15.98% | +37.19% | +6.79% | +3.40% | +13.58% | 128B | |
| -1.61% | +1.08% | -4.66% | +0.97% | -10.48% | -7.61% | -27.17% | -9.71% | +6.35% | 104B | |
| -1.18% | +6.04% | -0.56% | -2.37% | +2.90% | +27.46% | +24.72% | +6.98% | -8.72% | 102B | |
| +0.93% | +5.11% | -1.72% | -11.82% | -18.16% | +0.36% | +49.02% | +60.73% | +479.89% | 70.58B | |
| +0.37% | +5.50% | +8.25% | +20.86% | +23.43% | +34.72% | +22.80% | +56.52% | +29.82% | 60.94B | |
| -1.94% | -0.17% | -1.33% | +29.45% | +29.94% | +74.56% | -1.14% | +6.23% | -47.50% | 55.31B | |
| -0.26% | +1.02% | +1.02% | +18.53% | +36.72% | +95.58% | +284.23% | +335.58% | -23.39% | 45.67B | |
| +1.57% | +2.28% | -16.95% | -6.55% | -26.29% | -37.39% | +0.71% | -6.47% | +177.34% | 42.47B | |
| Average | -0.33% | +2.09% | -2.17% | +9.08% | +9.30% | +28.40% | +40.70% | +73.78% | +171.75% | 224.96B | |
| Weighted average by Cap. | -0.37% | +2.44% | -2.56% | +9.52% | +10.56% | +32.72% | +53.77% | +137.06% | +408.02% |
- Stock Market
- Stocks
- AFT Stock
- Sector AFT Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
